Dendrocalamus latiflorus and its component rutin exhibit glucose-lowering activities by inhibiting hepatic glucose production via AKT activation

Kun LUO; Wenting HUANG; Liansheng QIAO; Xiaoling ZHANG; Di YAN; Zhiyu NING; Chengmei MA; Honglei DANG; Dong WANG; Hongyan GUO; Lan XIE; Jing CHENG.
Acta Pharmaceutica Sinica B ; (6): 2239-2251, 2022.
Artículo en Inglés | WPRIM | ID: wpr-929406

Documentos relacionados

  1. <i>Dendrocalamus latiflorus</i> and its component rutin exhibit glucose-lowering activities by inhibiting hepatic glucose production <i>via</i> AKT activation.
  2. Biophysical and functional properties of purified glucose-6-phosphatase catalytic subunit 1.
  3. The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes.
  4. Hepatic cytokine-inducible SH2-containing protein (CISH) regulates gluconeogenesis via cAMP-responsive element binding protein (CREB).
  5. IPMK modulates hepatic glucose production and insulin signaling.
  6. Nonsynonymous single-nucleotide polymorphisms in the G6PC2 gene affect protein expression, enzyme activity, and fasting blood glucose.
  7. Regulation of basal expression of hepatic PEPCK and G6Pase by AKT2.
  8. Studies on glycogen storage disease type 1a animal models: a brief perspective.
  9. Modeling Phenotypic Heterogeneity of Glycogen Storage Disease Type 1a Liver Disease in Mice by Somatic CRISPR/CRISPR-associated protein 9-Mediated Gene Editing.
  10. Glucose-6-phosphatase catalytic subunit 2 negatively regulates glucose oxidation and insulin secretion in pancreatic ß-cells.